← back to search

Michael D. Keller

Jeffrey Modell Foundation · US
Area of research
Immunology · Epidemiology
Research interest
Research interests include Immunodeficiency and Autoimmune Disorders, Cytomegalovirus and herpesvirus research, CAR-T cell therapy research, and Virus-based gene therapy research.
h-index
33
citations
8,006
works
204
NIH funding
primary concept
Medicine
email

Recent publications

Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature
Science Immunology 2025cited by 14position: middledoi
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report
Blood Advances 2025cited by 2position: middledoi
Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC
Blood Advances 2025cited by 0position: middledoi
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
Nature Communications 2024cited by 23position: firstdoi
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium
The Lancet 2023cited by 110position: middledoi
Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations
Journal of Allergy and Clinical Immunology 2022cited by 62position: middledoi
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
Blood Advances 2022cited by 37position: middledoi
Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted
Blood Advances 2021cited by 54position: middledoi
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
Journal of Allergy and Clinical Immunology 2020cited by 360position: middledoi
SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
Blood 2020cited by 138position: firstdoi
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report
Blood 2020cited by 134position: middledoi
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers
Journal of Clinical Immunology 2020cited by 57position: middledoi
<i>Nfkb2</i> variants reveal a p100-degradation threshold that defines autoimmune susceptibility
The Journal of Experimental Medicine 2020cited by 31position: middledoi
Severe influenza pneumonitis in children with inherited TLR3 deficiency
The Journal of Experimental Medicine 2019cited by 192position: middledoi
Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma &amp; Immunology
Journal of Allergy and Clinical Immunology 2019cited by 95position: middledoi
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
Blood 2018cited by 174position: middledoi
Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes
Journal of Allergy and Clinical Immunology 2016cited by 127position: lastdoi

Grants

MRI: Acquisition of a Transmission Electron Microscope for Multidisciplinary Research and Education in Materials Science, Biology and Anthropology
NSF1828477$509,8152018–2021PIRePORTER
NRT-IGE: Workplace Inspired Approaches for Improving Graduate Student Professionalism
NSF1545211$484,5222015–2019PIRePORTER
CAREER: Self-Sensing and Sensitivity: Advanced Composites for Traditional Non-Destructive Evaluation (NDE)
NSF1351760$400,0002014–2020PIRePORTER
Collaborative Project: The Rosetta Project- ALL Language Archive
NSF0333689$36,0512003–2005PIRePORTER
ITR/CISE: LOCKSS
NSF0205667$1,930,4732002–2006PIRePORTER
SGER: Lots of Copies Keep Stuff Safe (LOCKSS) Government Documents
NSF0245231$49,6682002–2003PIRePORTER
SGER: Making Web Publishing Irreversible
NSF9907296$100,0001999–2002PIRePORTER

Frequent collaborators

Patrick J. Hanley · National Hospital3 papers (2016–2022)Catherine M. Bollard · e-Therapeutics (United Kingdom)3 papers (2016–2022)Carolina Colli Cruz · The University of Texas MD Anderson Cancer Center2 papers (2016–2022)Karin Chen · Maimonides Medical Center2 papers (2019–2020)Jordan S. Orange · Rockefeller University2 papers (2016–2019)Xavier Y.X. Sng · Monash University1 papers (2020–2020)Mark A. Vickers · University of Aberdeen1 papers (2016–2016)Ann M. Leen · Texas Children's Hospital1 papers (2016–2016)Helen E. Heslop · Baylor College of Medicine1 papers (2016–2016)Carolyn Lutzko · University of Vermont1 papers (2021–2021)Michail S. Lionakis · National Institute of Allergy and Infectious Diseases1 papers (2020–2020) · 1 papers (2022–2022)Caridad Martinez · Methodist Hospital1 papers (2016–2016)Stella M. Davies · Johns Hopkins University1 papers (2021–2021)Luigi D. Notarangelo · National Institutes of Health1 papers (2020–2020)Jolán E. Walter · University of South Florida1 papers (2019–2019)Michael Grimley · University of Cincinnati1 papers (2021–2021)Ottavia M. Delmonte · National Institutes of Health1 papers (2020–2020)Janet Chou · Harvard University1 papers (2019–2019)Anna Chan · Australian Regenerative Medicine Institute1 papers (2020–2020)